LaRon Pharma

Laronde is a biotechnology company pioneering a new class of programmable medicines called Endless RNA (eRNA). Unlike traditional mRNA, eRNA is a closed-loop structure that lacks the ends typically recognized by the body's innate immune system, allowing for increased stability and prolonged protein expression. The company's platform aims to create a multi-product pipeline across various therapeutic areas, including rare diseases, oncology, and cardiology. Founded by Flagship Pioneering, Laronde is focused on scaling its eRNA technology to develop treatments that can be administered repeatedly and provide long-lasting therapeutic effects.